Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Subiaco
Clinical trial register · Australia

Clinical Trials in Subiaco, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Daiichi Sankyo6 Boehringer Ingelheim3 Genmab3 Merck Sharp & Dohme LLC2 AstraZeneca2
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Subiaco

42 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Genmab
Phase 2
160
Subiaco, Adelaide
2026-05-11
Recruiting
Boehringer Ingelheim
Phase 3
400
Bedford Park, Subiaco, Heidelberg, Sydney, Woolloongabba
2026-01-16
Recruiting
Taiho Oncology, Inc.
Phase 3
360
Bankstown, St Leonards, Subiaco
2025-12-22
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
Macquarie University, Brisbane, Ballarat Central, Heidelberg, Melbourne, Subiaco
2025-09-11
Recruiting
AstraZeneca
Phase 3
800
Malvern, Melbourne, Randwick, St Leonards, Subiaco, Westmead
2025-08-01
Recruiting
BioNTech SE
Phase 1/2
594
Camperdown, Bedford Park, Bendigo, Geelong, Saint Albans, Subiaco
2025-05-02
Active, closed
Immutep S.A.S.
Phase 3
756
Elizabeth Vale, Greenslopes, Melbourne, Southport, Subiaco, Tiwi, Waratah, Wollongong
2025-03-21
Recruiting
Daiichi Sankyo
Phase 3
726
Bedford Park, Clayton, Douglas, North Melbourne, St Leonards, Subiaco, Wollongong
2025-02-27
Active, closed
Genmab
Phase 3
584
New Lambton Heights, South Brisbane, Subiaco
2025-02-07
Recruiting
Bristol-Myers Squibb
Phase 1/2
416
Liverpool, Woolloongabba, Melbourne, Subiaco
2025-02-04
Active, closed
Genmab
Phase 3
191
Camperdown, Sydney, Southport, Bedford Park, Perth, Subiaco, Fitzroy, Wendouree
2024-11-25
Recruiting
Boehringer Ingelheim
Phase 2
588
Macquarie Park, St Leonards, Woolloongabba, Adelaide, Subiaco
2024-10-11
Recruiting
Jazz Pharmaceuticals
Phase 3
550
Birtinya, Melbourne, Mount Waverly, Adelaide, Mount Kuring-Gai, Subiaco
2024-08-13
Recruiting
Daiichi Sankyo
Phase 3
540
Ballarat, Bedford Park, Camperdown, St Albans, Subiaco, Townsville, Woolloongabba
2024-05-21
Recruiting
Daiichi Sankyo
Phase 1/2
680
Blacktown, Mount Kuring-Gai, St Leonards, Woolloongabba, Subiaco
2024-04-10
Active, closed
Cochlear
Not applicable
148
Subiaco
2024-03-18
Recruiting
A Prospective, Pre-market, Multi-center Study of Insignia Hip Stem in THA to Determine Implant Survivorship and PROMS.
NCT06108934Arthritis (E.G., Degenerative Joint Disease (DJD), Osteoarthritis, and Rheumatoid Arthritis (RA))
Stryker Australia Pty Ltd.
Not applicable
313
Subiaco
2024-02-22
Active, closed
Boehringer Ingelheim
Phase 3
428
Randwick, St Leonards, Woolloongabba, Heidelberg, Subiaco
2024-02-09
Recruiting
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
NCT06022029Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Lymphoma, Non-Hodgkin
DrugCemiplimab
OncoNano Medicine, Inc.
Phase 1
168
Darlinghurst, Wollongong, Buderim, Southport, Woolloongabba, Bedford Park, Subiaco
2023-10-13
Recruiting
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
NCT05727176Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement
DrugFutibatinib
Taiho Oncology, Inc.
Phase 2
120
Sydney, Melbourne, Subiaco
2023-07-05
Active, closed
Servier Affaires Médicales
Phase 3
299
Brisbane, Fitzroy, Subiaco, Sydney, Woodville
2023-05-03
Active, closed
AbbVie
Phase 3
520
Westmead, Southport, Ballarat, Clayton, Malvern, Melbourne, Richmond, Subiaco
2023-03-15
Active, closed
BeiGene
Phase 2
400
Blacktown, Camperdown, Frenchs Forest, Port Macquarie, Nedlands, Subiaco
2023-03-07
Active, closed
Daiichi Sankyo
Phase 3
586
Camperdown, Kogarah, Liverpool, Melbourne, Subiaco, Woolloongabba
2022-07-08
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
654
Camperdown, Macquarie University, Westmead, Adelaide, Bedford Park, Box Hill, Heidelberg, Subiaco
2022-03-07
Recruiting
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 2
310
Chermside, South Brisbane, Adelaide, Toorak Gardens, East Melbourne, Nedlands, Subiaco
2022-02-17
Active, closed
Merck Sharp & Dohme LLC
Phase 3
280
St Leonards, Westmead, Brisbane, Clayton, Melbourne, Subiaco
2022-02-03
Active, closed
Merck Sharp & Dohme LLC
Phase 3
643
Westmead, Brisbane, Melbourne, Subiaco
2021-12-13
Active, closed
AstraZeneca
Phase 3
506
Adelaide, Auchenflower, Clayton, Heidelberg, St Leonards, Subiaco
2021-06-22
Active, closed
Columbia University
Observational
122
Adelaide, Chatswood, East Melbourne, Maribyrnong, North Adelaide, Subiaco, Sydney
2021-05-06
Active, closed
Murdoch Childrens Research Institute
Not applicable
906
South Brisbane, Adelaide, Melbourne, Parkville, Subiaco
2021-05-04
Active, closed
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
NCT04619004Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 2
277
Blacktown, Camperdown, Kogarah, Melbourne, Subiaco, Woolloongabba
2021-02-02
Active, closed
Daiichi Sankyo
Phase 3
1,600
Adelaide, Camperdown, Clayton, Heidelberg, Melbourne, Nedlands, Saint Leonards, Subiaco
2020-12-04
Recruiting
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
NCT04606446Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
DrugsPrifetrastat·Atirmociclib·Palbociclib·Letrozole
Pfizer
Phase 2
320
Camperdown, Adelaide, Melbourne, Parkville, St Albans, Subiaco
2020-11-16
Active, closed
Novartis Pharmaceuticals
Phase 2
134
North Sydney, Wooloongabba, Subiaco
2020-10-30
Active, closed
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
NCT04185883Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation
DrugsBI 1701963·TNO155·Sotorasib·Afatinib
Amgen
Phase 1
610
Kingswood, St Leonards, South Brisbane, Woodville South, Subiaco
2019-12-17
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Camberwell, Clayton, Footscray, Murdoch, Perth, South Brisbane, Subiaco, Woolloongabba
2019-09-26
Active, closed
ModernaTX, Inc.
Phase 2
267
North Sydney, Westmead, Woolloongabba, Murdoch, Subiaco
2019-07-18
Active, closed
AbbVie
Phase 2
270
Darlinghurst, Lambton Heights, Tweed Heads, South Brisbane, Subiaco
2018-10-10
Active, closed
Canadian Cancer Trials Group
Phase 2
117
Camperdown, Randwick, Westmead, Melbourne, Subiaco
2018-07-24
Active, closed
pharmaand GmbH
Phase 3
1,097
New Lambton Heights, Saint Leonards, Sydney, Westmead, Brisbane, Toorak Gardens, Melbourne, Subiaco
2018-05-14
Active, closed
Eli Lilly and Company
Phase 3
669
South Brisbane, Southport, Kurralta Park, East Bentleigh, Subiaco
2014-07-22
Rows per page Showing 1–42 of 42
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/subiaco

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 42 of those studies with a site in Subiaco.

How many clinical trials are recruiting in Subiaco?

17 of the 42 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 25 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Subiaco), 42 studies
PhaseStudiesRecruitingShare
Phase 320647.6%
Phase 211526.2%
Not applicable317.1%
Phase 1/2337.1%
Phase 1214.8%
Phase 2/3214.8%
Observational102.4%

Most active sponsors

Lead sponsors with the most studies (Subiaco)
Lead sponsorStudiesRecruiting
Daiichi Sankyo63
Boehringer Ingelheim32
Genmab31
AbbVie20
AstraZeneca21
Bristol-Myers Squibb22
Merck Sharp & Dohme LLC20
Taiho Oncology, Inc.22
Amgen10
BeiGene10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.